NY S 4459
in committeeRelates to adding W-18 to the schedule of controlled substances
New York · 2025-2026 Regular Session · upper
Quick answers
Did NY S 4459 pass?
Not yet. NY S 4459 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO HEALTH
What is NY S 4459 about?
Adds W-18(4-chloro-N-{1-{2-(4-nitrophenyl)ethyl} 2piperidinylidene}benzenesulfonamide) to the schedule of controlled substances.
Who sponsors NY S 4459?
James Skoufis is the primary sponsor of NY S 4459.
Description
Adds W-18(4-chloro-N-{1-{2-(4-nitrophenyl)ethyl} 2piperidinylidene}benzenesulfonamide) to the schedule of controlled substances.
- Introduced
- —
- Latest action
- 2026-01-07 — REFERRED TO HEALTH
- Bill type
- bill
- Last updated
- —
Sponsors
- James Skoufisprimary
Committees
Not provided by source.
Action timeline
2025-02-05
REFERRED TO HEALTH
referral-committee
2026-01-07
REFERRED TO HEALTH
referral-committee
Versions
- S4459Compare
Documents
Votes
Not provided by source.
Related bills
- Prior session: S 5112not in this corpus
- Prior session: S 5221not in this corpus
- Prior session: S 1774not in this corpus
- Prior session: S 1758not in this corpus
- Companion bill: A 7748
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 4459. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.